What is Aclaris Therapeutics's capex?

Aclaris Therapeutics (ACRS) reported capex of $13K in Q1 2026.

How has Aclaris Therapeutics's capex changed year-over-year?

Aclaris Therapeutics's capex decreased by 69.8% year-over-year, from $43K to $13K.

What is the long-term trend for Aclaris Therapeutics's capex?

Over 2 years (2022 to 2025), Aclaris Therapeutics's capex has grown at a -57.2% compound annual growth rate (CAGR), from $605K to $111K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Aclaris Therapeutics ACRS CapEx

CapEx at other companies

Corvus PharmaceuticalsCRVS

$91K+153%

Shattuck Labs, Inc.STTK

$63K—

Apogee Therapeutics, Inc.APGE

$62K—

Kymera TherapeuticsKYMR

$434K-7.1%

CytomX TherapeuticsCTMX

$0-100%

IncyteINCY

——

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's capex?: Aclaris Therapeutics (ACRS) reported capex of $13K in Q1 2026.
How has Aclaris Therapeutics's capex changed year-over-year?: Aclaris Therapeutics's capex decreased by 69.8% year-over-year, from $43K to $13K.
What is the long-term trend for Aclaris Therapeutics's capex?: Over 2 years (2022 to 2025), Aclaris Therapeutics's capex has grown at a -57.2% compound annual growth rate (CAGR), from $605K to $111K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.